Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
128.3 USD | -0.42% | -1.88% | +17.65% |
02/05 | Merck: encouraging results in gastric cancer | CF |
01/05 | Merck Says Keytruda Meets Primary Endpoint in Late-Stage Gastric Cancer Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.65% | 325B | |
+29.68% | 681B | |
+25.07% | 556B | |
-4.35% | 361B | |
+3.77% | 285B | |
+14.68% | 235B | |
+4.71% | 199B | |
-12.43% | 189B | |
-3.79% | 157B | |
-3.34% | 149B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- SVB Leerink Adjusts Merck & Co.'s Price Target to $102 from $105, Keeps Outperform Rating